Gamida Cell Ltd. (GMDA) Tops Q1 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Pre-Open Stock Movers 05/19: (ABUS) (DVAX) (AAP) Higher; (BLPH) (GMDA) (GOOS) Lower (more...)
May 19, 2020 9:30 AM EDTPre-Open Stock Movers:
Arbutus Biopharma Corporation (Nasdaq: ABUS) 42.2% HIGHER; reports positive follow-up data from a Phase 1a/1b clinical trial (AB-729-001) in chronic HBV subjects on nucleos(t)ide therapy who received a single subcutaneous injection of 60 mg of AB-729, a proprietary GalNAc delivered RNAi compound.
Dynavax (Nasdaq: DVAX) 40.3% HIGHER; intends to provide an update on its early-stage collaborations regarding the potential development of a vaccine for COVID-19
Bellerophon Therapeutics, Inc. (Nasdaq:... More
Gamida Cell Ltd. (GMDA) Prices 13.334M Share Common Offering at $4.50/Sh
May 19, 2020 5:48 AM EDTGamida Cell Ltd. (NASDAQ: GMDA) today announced the pricing of an underwritten public offering of 13,333,334 ordinary shares at a public offering price of $4.50 per share for aggregate gross proceeds of approximately $60 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition,... More
